LeMaitre Vascular, Inc. (LMAT) Financial Ratios
22 years of historical data (2004–2025) · Healthcare · Medical - Instruments & Supplies
EV/EBITDA
↑
29.33
+4% vs avg
5yr avg: 28.25
30Y Low11.3·High70.1
P/FCF
↓
28.74
↓-30% vs avg
5yr avg: 41.27
30Y Low20.9·High87.2
P/B Ratio
↑
5.47
+18% vs avg
5yr avg: 4.65
30Y Low0.8·High6.2
ROE
↑
15.8%
↓+30% vs avg
5yr avg: 12.2%
30Y Low-7%·High19%
Debt/EBITDA
↑
2.37
↑+80% vs avg
5yr avg: 1.32
30Y Low0.1·High3.0
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
LMAT Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
LeMaitre Vascular, Inc. trades at 37.3x earnings, 12% below its 5-year average of 42.4x, sitting at the 35th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 69%. On a free-cash-flow basis, the stock trades at 28.7x P/FCF, 30% below the 5-year average of 41.3x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.1B | $1.9B | $2.1B | $1.3B | $1.0B | $1.1B | $829M | $731M | $479M | $638M | $488M |
| Enterprise Value | $2.3B | $2.0B | $2.3B | $1.3B | $1.0B | $1.1B | $857M | $735M | $452M | $619M | $463M |
| P/E Ratio → | 37.28 | 32.18 | 47.74 | 42.36 | 49.48 | 40.18 | 38.94 | 40.85 | 20.92 | 37.02 | 46.07 |
| P/S Ratio | 8.57 | 7.45 | 9.55 | 6.58 | 6.31 | 6.99 | 6.41 | 6.23 | 4.53 | 6.32 | 5.47 |
| P/B Ratio | 5.47 | 4.73 | 6.22 | 4.27 | 3.80 | 4.24 | 4.81 | 4.93 | 3.67 | 5.81 | 5.57 |
| P/FCF | 28.74 | 24.97 | 56.48 | 43.16 | 46.07 | 35.69 | 26.07 | 70.14 | 29.09 | 38.77 | 34.69 |
| P/OCF | 26.34 | 22.89 | 47.57 | 34.63 | 40.20 | 30.73 | 23.83 | 51.54 | 24.53 | 27.89 | 28.86 |
P/E links to full P/E history page with 30-year chart
LMAT EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
LeMaitre Vascular, Inc.'s enterprise value stands at 29.3x EBITDA, roughly in line with its 5-year average of 28.3x. The Healthcare sector median is 14.2x, placing the stock at a 106% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 8.08 | 10.27 | 6.55 | 6.30 | 7.00 | 6.63 | 6.27 | 4.28 | 6.13 | 5.20 |
| EV / EBITDA | 29.33 | 25.75 | 36.48 | 27.42 | 28.07 | 23.55 | 23.17 | 27.62 | 13.90 | 24.59 | 23.25 |
| EV / EBIT | 33.83 | 25.10 | 39.57 | 32.11 | 37.02 | 29.61 | 29.91 | 33.89 | 15.90 | 29.32 | 28.50 |
| EV / FCF | — | 27.08 | 60.79 | 42.99 | 45.95 | 35.76 | 26.95 | 70.52 | 27.49 | 37.61 | 32.97 |
LMAT Profitability
Margins and return-on-capital ratios measuring operating efficiency
LeMaitre Vascular, Inc. earns an operating margin of 27.2%. Operating margins have expanded from 19.0% to 27.2% over the past 3 years, signaling improving operational efficiency. ROE of 15.8% indicates solid capital efficiency. ROIC of 9.7% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.5% | 71.5% | 68.6% | 65.7% | 64.9% | 65.7% | 65.4% | 68.1% | 70.0% | 70.1% | 70.6% |
| Operating Margin | 27.2% | 27.2% | 23.8% | 19.0% | 16.6% | 23.6% | 22.3% | 18.1% | 26.7% | 20.9% | 18.3% |
| Net Profit Margin | 23.1% | 23.1% | 20.0% | 15.6% | 12.8% | 17.4% | 16.4% | 15.3% | 21.7% | 17.0% | 11.9% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 15.8% | 15.8% | 13.9% | 10.6% | 7.9% | 12.6% | 13.2% | 12.9% | 19.1% | 17.4% | 12.8% |
| ROA | 9.9% | 9.9% | 9.8% | 9.2% | 6.8% | 9.9% | 9.6% | 10.5% | 16.4% | 15.1% | 11.0% |
| ROIC | 9.7% | 9.7% | 9.9% | 9.9% | 7.7% | 12.0% | 12.2% | 12.4% | 21.7% | 20.6% | 21.6% |
| ROCE | 12.3% | 12.3% | 12.5% | 12.2% | 9.6% | 14.6% | 14.6% | 14.1% | 22.9% | 20.6% | 19.0% |
LMAT Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
LeMaitre Vascular, Inc. carries a Debt/EBITDA ratio of 2.4x, which is manageable (26% below the sector average of 3.2x). Net debt stands at $157M ($186M total debt minus $28M cash). Interest coverage of 15.5x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.47 | 0.47 | 0.55 | 0.06 | 0.06 | 0.06 | 0.32 | 0.11 | — | — | — |
| Debt / EBITDA | 2.37 | 2.37 | 3.00 | 0.41 | 0.46 | 0.35 | 1.48 | 0.59 | — | — | — |
| Net Debt / Equity | — | 0.40 | 0.47 | -0.02 | -0.01 | 0.01 | 0.16 | 0.03 | -0.20 | -0.17 | -0.28 |
| Net Debt / EBITDA | 2.01 | 2.01 | 2.58 | -0.11 | -0.07 | 0.05 | 0.76 | 0.15 | -0.81 | -0.76 | -1.22 |
| Debt / FCF | — | 2.11 | 4.31 | -0.18 | -0.11 | 0.07 | 0.88 | 0.38 | -1.60 | -1.16 | -1.73 |
| Interest Coverage | 15.50 | 15.50 | 278.44 | — | — | 16.45 | 21.88 | — | 14223.00 | 1005.05 | 1161.14 |
LMAT Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
LeMaitre Vascular, Inc.'s current ratio of 12.89x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 10.95x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 6.51x to 12.89x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.89 | 12.89 | 13.14 | 6.51 | 6.39 | 6.41 | 3.75 | 4.42 | 4.76 | 6.09 | 5.63 |
| Quick Ratio | 10.95 | 10.95 | 11.31 | 4.76 | 4.60 | 4.55 | 2.19 | 2.76 | 3.46 | 4.49 | 3.76 |
| Cash Ratio | 9.89 | 9.89 | 9.79 | 3.52 | 3.26 | 3.21 | 1.07 | 1.57 | 2.43 | 3.16 | 2.32 |
| Asset Turnover | — | 0.41 | 0.40 | 0.56 | 0.52 | 0.53 | 0.51 | 0.62 | 0.69 | 0.80 | 0.87 |
| Inventory Turnover | 1.01 | 1.01 | 1.23 | 1.27 | 1.25 | 1.30 | 1.14 | 1.08 | 1.24 | 1.43 | 1.34 |
| Days Sales Outstanding | — | 49.15 | 49.91 | 47.28 | 49.77 | 46.40 | 55.16 | 51.60 | 54.36 | 54.28 | 54.01 |
LMAT Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
LeMaitre Vascular, Inc. returns 0.8% to shareholders annually primarily through dividends. The payout ratio of 31.4% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 2.7% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.8% | 1.0% | 0.7% | 1.0% | 1.1% | 0.9% | 0.9% | 0.9% | 1.1% | 0.7% | 0.7% |
| Payout Ratio | 31.4% | 31.4% | 32.6% | 41.3% | 53.2% | 34.7% | 36.3% | 37.6% | 23.7% | 24.3% | 31.4% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.7% | 3.1% | 2.1% | 2.4% | 2.0% | 2.5% | 2.6% | 2.4% | 4.8% | 2.7% | 2.2% |
| FCF Yield | 3.5% | 4.0% | 1.8% | 2.3% | 2.2% | 2.8% | 3.8% | 1.4% | 3.4% | 2.6% | 2.9% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.2% | 0.1% | 0.1% |
| Total Shareholder Yield | 0.8% | 1.0% | 0.7% | 1.0% | 1.1% | 0.9% | 1.0% | 1.0% | 1.3% | 0.8% | 0.7% |
| Shares Outstanding | — | $23M | $23M | $22M | $22M | $21M | $20M | $20M | $20M | $20M | $19M |
Peer Comparison
Compare LMAT with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 LMATYou | $2B | 37.3 | 29.3 | 28.7 | 71.5% | 27.2% | 15.8% | 9.7% | 2.4 |
 ATRC | $1B | -120.0 | 80.7 | 30.2 | 74.4% | -0.6% | -2.4% | -0.6% | 5.2 |
 NVCR | $2B | -11.7 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 ANGO | $505M | -14.6 | — | — | 53.9% | -13.7% | -17.5% | -22.9% | — |
 CNMD | $1B | 21.6 | 9.3 | 6.7 | 52.8% | 10.3% | 4.7% | 5.8% | 4.3 |
 MMSI | $4B | 31.6 | 14.0 | 18.6 | 48.7% | 12.2% | 8.7% | 7.2% | 2.8 |
 TMDX | $3B | 16.2 | 19.9 | 20.4 | 59.9% | 17.9% | 54.2% | 18.8% | 3.5 |
 ELMD | $320M | 45.0 | 27.6 | 28.9 | 78.1% | 15.4% | 17.2% | 26.1% | 0.0 |
 PCVX | $7B | -9.1 | — | — | — | — | -25.6% | -24.2% | — |
 NVST | $4B | 92.5 | 13.8 | 18.3 | 55.0% | 8.3% | 1.6% | 4.8% | 5.0 |
 BSX | $67B | 23.3 | 20.8 | 18.4 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 22 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
LMAT — Frequently Asked Questions
Quick answers to the most common questions about buying LMAT stock.
What is LeMaitre Vascular, Inc.'s P/E ratio?
LeMaitre Vascular, Inc.'s current P/E ratio is 37.3x. The historical average is 38.8x. This places it at the 35th percentile of its historical range.
What is LeMaitre Vascular, Inc.'s EV/EBITDA?
LeMaitre Vascular, Inc.'s current EV/EBITDA is 29.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 23.7x.
What is LeMaitre Vascular, Inc.'s ROE?
LeMaitre Vascular, Inc.'s return on equity (ROE) is 15.8%. The historical average is 7.9%.
Is LMAT stock overvalued?
Based on historical data, LeMaitre Vascular, Inc. is trading at a P/E of 37.3x. This is at the 35th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What is LeMaitre Vascular, Inc.'s dividend yield?
LeMaitre Vascular, Inc.'s current dividend yield is 0.84% with a payout ratio of 31.4%.
What are LeMaitre Vascular, Inc.'s profit margins?
LeMaitre Vascular, Inc. has 71.5% gross margin and 27.2% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
How much debt does LeMaitre Vascular, Inc. have?
LeMaitre Vascular, Inc.'s Debt/EBITDA ratio is 2.4x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.